Aquestive Therapeutics, Inc. (AQST)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$4.46
+4.69%
Mkt Cap $419.07M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$9.00
Range $6.00 – $12.00
Implied Upside
+101.8%
Consensus $9.00 vs current $4.46